# Dose-Escalation of Botulinum Toxin in Subjects With Osteoarthritis of the Knee

> **NCT02139319** · PHASE1 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 22 (actual)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DRUG:** Botulinum toxin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02139319
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2022-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02139319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02139319, "Dose-Escalation of Botulinum Toxin in Subjects With Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02139319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*